GURU.Markets stock price, segment price, and overall market index valuation
The company's share price electroCore Inc.
electroCore is a medical device company that has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. Its stock price reflects its struggle to widely adopt this technology and gain insurance coverage.
Share prices of companies in the market segment - Therapeutic medical equipment
electroCore is a medical company that has developed a non-invasive vagus nerve stimulation technology for the treatment of headaches. We've classified it as a "Therapeutic Medical Equipment" product. The chart below shows how the market is evaluating new approaches to chronic pain treatment.
Broad Market Index - GURU.Markets
electroCore is a medical company that has developed a non-invasive vagus nerve stimulation technology for the treatment of headaches. As a component of the GURU.Markets index, it offers new approaches to chronic pain treatment. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
ECOR - Daily change in the company's share price electroCore Inc.
ElectroCore, Inc.'s daily price change reflects volatility in the medical device sector. The indicator is sensitive to sales of its neurostimulators and news about expanded indications.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
electroCore, Inc. is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing this to ECOR, which focuses on non-invasive neurostimulation, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
electroCore produces non-invasive devices for vagus nerve stimulation to treat headaches. The stock price of this medical technology company depends on the adoption of its technology in medical practice. Such unique stories are part of a larger market whose overall volatility you can see.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization electroCore Inc.
For electroCore, Inc., the year-over-year performance is a story of commercialization of its non-invasive vagus nerve stimulation technology. Its 12-month market cap growth reflects increased sales of its gammaCore device for treating migraines and other types of pain, as well as its success in expanding insurance coverage for this therapy.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
electroCore, Inc. is a commercial medical device company that has developed a non-invasive technology for vagus nerve stimulation to treat headaches. This chart shows how its innovative technology, efforts to expand insurance coverage, and competition are impacting its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
electroCore, with its non-invasive nerve stimulation device, is a growth story in medicine. Its stock price is driven not by economics, but by its success in commercialization and regulatory approvals. The chart reflects the potential of this breakthrough technology in the vast pain treatment market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization electroCore Inc.
electroCore is a commercial medical device company producing non-invasive vagus nerve stimulators. Its monthly growth is driven by sales growth of its devices. Quarterly revenue reports and expanded indications are key drivers of its valuation.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
electroCore develops non-invasive devices for vagus nerve stimulation to treat headaches. This "bioelectronic medicine" sector offers an alternative to pills. The chart below shows how investors assessed the commercial potential of new non-drug treatments and their ability to gain the trust of doctors and patients.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
electroCore is a medical company that produces non-invasive devices for vagus nerve stimulation (for the treatment of headaches). Its stock price is driven by sales volumes, expanded indications, and insurance coverage decisions.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization electroCore Inc.
electroCore is a medical company developing non-invasive vagus nerve therapy for the treatment of headaches. Weekly stock performance is driven by sales growth, results of new clinical trials expanding indications, and insurance company reimbursement decisions.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
electroCore is a medical company developing non-invasive vagus nerve therapy for the treatment of headaches. Weekly stock performance is driven by sales growth, results of new clinical trials expanding indications, and insurance company reimbursement decisions.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Shares of electroCore, a medical technology company, live in a world of their own. Their performance is determined by sales and research news. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can move regardless of the broader market.
Market capitalization of the company, segment and market as a whole
ECOR - Market capitalization of the company electroCore Inc.
The valuation of electroCore is the story of non-invasive vagus nerve stimulation for headache treatment. This medical company's timeline reflects the long and arduous journey to acceptance of this technology by doctors and insurance companies. It's a visualization of the difficulty of commercializing an innovative yet unconventional treatment method.
ECOR - Share of the company's market capitalization electroCore Inc. within the market segment - Therapeutic medical equipment
electroCore is a commercial company that produces non-invasive vagus nerve stimulation devices for the treatment of headaches. Its market share reflects its position in the segment. The chart below shows how investors view the growth of its device sales and the expansion of its indications.
Market capitalization of the market segment - Therapeutic medical equipment
electroCore has developed a non-invasive device for vagus nerve stimulation to treat headaches. The chart below shows the overall market capitalization of the therapeutic medical equipment sector. It illustrates the trend toward non-drug and non-invasive treatments for chronic conditions.
Market capitalization of all companies included in a broad market index - GURU.Markets
This non-invasive pain treatment is shown here. electroCore developed a device that stimulates the vagus nerve to treat migraines and other types of pain. Its line on the graph tells the story of the difficult journey to convince doctors, patients, and insurance companies of the effectiveness of this new technology.
Book value capitalization of the company, segment and market as a whole
ECOR - Book value capitalization of the company electroCore Inc.
electroCore's foundation is its intellectual property for non-invasive vagus nerve stimulation technology for the treatment of headaches and other disorders. This represents unique medical capital. The chart below shows how the company is managing its resources to commercialize its portable medical devices.
ECOR - Share of the company's book capitalization electroCore Inc. within the market segment - Therapeutic medical equipment
electroCore is a medical device company that produces non-invasive vagus nerve stimulation devices for the treatment of headaches. Its assets are assembly lines. The chart shows the company's share of the physical infrastructure for the production of this innovative neuromodulation therapy.
Market segment balance sheet capitalization - Therapeutic medical equipment
Medical device development, as the BCap_Ges chart shows, is capital-intensive. electroCore, in developing its non-invasive vagus nerve stimulators, must invest in R&D and manufacturing to ensure the quality and reliability of its physical products.
Book value of all companies included in the broad market index - GURU.Markets
electroCore's assets are production lines for non-invasive neurostimulators for headache treatment. Their book value reflects the physical scale of production, which creates tangible medical devices offering an alternative to traditional medications.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - electroCore Inc.
electroCore produces a non-invasive device for vagus nerve stimulation for the treatment of headaches. The company's value lies in its patented technology, not its assets. MvsBCap's earnings schedule will reflect its success in commercializing this medical device and securing approvals for its use in new conditions.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
electroCore is a company that produces non-invasive vagus nerve stimulation devices for headache treatment. Its value lies in its patented technology. The chart shows how the market values its unique approach to pain therapy.
Market to book capitalization ratio for the market as a whole
electroCore has developed a non-invasive device for vagus nerve stimulation to treat headaches. The company's value lies in this patented technology. Its market valuation reflects the device's potential as a drug alternative. The chart shows how the market values medical devices that offer a new approach to therapy.
Debts of the company, segment and market as a whole
ECOR - Company debts electroCore Inc.
electroCore, a company that developed a non-invasive vagus nerve stimulation device for headache treatment, is using capital to commercialize its technology. Convincing doctors and patients of the effectiveness of this new approach requires significant investment in marketing and clinical data. This chart shows how the company is funding the rollout of its innovative product.
Market segment debts - Therapeutic medical equipment
electroCore, Inc. is commercializing a non-invasive vagus nerve stimulation technology for the treatment of headaches. Bringing a new medical device to market requires significant investment in clinical research and marketing. This chart shows how the company funds the advancement of its unique therapeutic technology.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio electroCore Inc.
electroCore develops non-invasive medical devices for the treatment of headaches. This chart shows how the company is funding its research and commercialization. Its reliance on debt could become a problem if sales don't reach projected levels or insurance companies refuse to cover the costs of its technology.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
electroCore is a company that produces non-invasive vagus nerve stimulation devices for the treatment of headaches. The chart shows the overall debt burden in the medical device sector. It helps assess how the company is funding the commercialization of its unique technology and how its financial structure compares to other therapeutic device manufacturers.
Debt to book value of all companies in the market
electroCore, Inc. is a commercial bioelectronic medical company that has developed a non-invasive therapy for headaches. This chart reflects the overall financial health of the healthcare system. The company's ability to expand sales depends on patient solvency and the willingness of insurers to cover new treatments.
P/E of the company, segment and market as a whole
P/E - electroCore Inc.
The chart for electroCore, Inc., a company that produces medical devices for non-invasive vagus nerve stimulation, shows how the market is evaluating its technology. The dynamics reflect investor expectations for the application of this method for treating migraines and other conditions, as well as the challenges associated with its commercialization.
P/E of the market segment - Therapeutic medical equipment
This chart shows the average P/E for the medical device sector, where electroCore offers non-invasive therapies. This metric helps understand how the market views the commercial potential of electroCore's unique technology compared to other medical devices and therapeutic solutions.
P/E of the market as a whole
electroCore is a medical company that has developed a non-invasive device for vagus nerve stimulation for the treatment of headaches. It is an alternative to drug therapy. This chart shows the mood in the medtech sector. It helps understand how the market views the potential of non-invasive neuromodulation to capture share in the vast market for migraine and other pain treatments compared to traditional methods.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company electroCore Inc.
electroCore is a medical company that has developed a non-invasive device for vagus nerve stimulation to treat headaches. The company's growth depends on the acceptance of its technology by patients and doctors. This chart reflects analysts' forecasts for sales of this device and its potential for treating other conditions.
%20P%2FE%20electroCore%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-electroCore-Inc.&v=1772513429265 "Chart of the company's future (projected) P/E electroCore Inc.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
electroCore is a medical device company that has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. This chart shows how its future revenue expectations compare to the industry average. Does the market value its unique technology as an alternative to traditional medications?
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772513429335 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
electroCore is a medical company that has developed a non-invasive vagus nerve stimulation therapy for the treatment of headaches. Its success depends on the commercialization of this technology. This chart, reflecting overall market sentiment, influences the willingness of the healthcare system and investors to support new medical devices. Optimism accelerates their adoption.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513429381 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit electroCore Inc.
electroCore, Inc. produces a non-invasive vagus nerve stimulation device used to treat headaches. The company's profits depend on sales of this device and its acceptance by the medical community. This chart shows the company's journey from FDA approval to building a sustainable commercial model and achieving profitability.
Profit of companies in the market segment - Therapeutic medical equipment
electroCore is a medical device company that has developed a non-invasive vagus nerve stimulation device used to treat migraines and other headaches. This chart shows the overall profitability of the therapeutic device sector, where drug-free and non-invasive treatments are increasingly in demand among patients and physicians.
Overall market profit
electroCore produces medical devices for non-invasive vagus nerve stimulation for the treatment of headaches. Demand for these devices depends on their effectiveness and insurance coverage. The overall economic situation, reflected in the graph, influences insurers' ability to expand coverage for new treatments.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company electroCore Inc.
electroCore is a medical device company that has developed a non-invasive vagus nerve stimulation device used to treat headaches. This chart reflects analyst expectations for the rate of adoption of this therapy by doctors and patients, and, consequently, future sales growth and profitability of the company.
%20profit%20of%20the%20company%20electroCore%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-electroCore-Inc.&v=1772513429606 "Graph of future (projected) profit of the company electroCore Inc.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
electroCore, Inc. has commercialized a non-invasive vagus nerve stimulation (nVNS) device used to treat headaches. The company is also exploring the application of its technology to other conditions. This chart shows profitability forecasts for the medical device sector, helping to assess the potential of innovative neurostimulation methods in medicine.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772513429663 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
electroCore is a medical company developing a non-invasive therapy for headaches. Its success depends on the acceptance of the technology by doctors and patients, as well as the insurance reimbursement system. This graph, reflecting economic expectations, indirectly affects the healthcare system's financial capacity and willingness to pay for innovative treatments.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513429679 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - electroCore Inc.
electroCore produces non-invasive medical devices for vagus nerve stimulation. This chart shows how the market is assessing the commercialization of its unique technology. The ratio is an indicator of the acceptance of its therapy by doctors and patients for various conditions.
P/S market segment - Therapeutic medical equipment
electroCore, Inc. is a bioelectronic medicine company that has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. This chart shows the average revenue estimate for the medical device sector. It provides an insight into the market's perception of electroCore's innovative approach to drug-free pain management.
P/S of the market as a whole
electroCore is a commercial company that has developed a non-invasive device for vagus nerve stimulation to treat headaches. Their technology offers an alternative to medications. This chart shows the average market revenue estimate, helping to understand how investors value medical devices that offer new approaches to treating common conditions.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company electroCore Inc.
electroCore has developed a non-invasive device for vagus nerve stimulation used to treat headaches. This chart shows how the market estimates future sales of this technology. This estimate depends on its acceptance by doctors and patients as an alternative to drug treatment and the expansion of its indications.
%20P%2FS%20electroCore%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-electroCore-Inc.&v=1772513429790 "The graph of the company's future (projected) P/S electroCore Inc.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
electroCore is a commercial bioelectronic medical company that has developed a non-invasive device for vagus nerve stimulation for the treatment of headaches. This chart shows how the market values its unique technology and future sales compared to the therapeutic medical device sector.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772513429819 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
electroCore is a medical company that has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. This chart, reflecting expectations for rising consumer spending on healthcare, is important to the company. Economic confidence allows people to spend more on alternative and innovative treatments to improve their quality of life.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513429867 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales electroCore Inc.
electroCore is a commercial bioelectronic medical company that has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. This chart shows revenue from sales of these devices. The growth here reflects the acceptance of this innovative therapy by doctors and patients as an alternative to drug treatment.
Sales of companies in the market segment - Therapeutic medical equipment
electroCore, Inc. is a bioelectronic medicine company that has developed a non-invasive vagus nerve stimulation technology for the treatment of headaches and other disorders. The company's business is segmented by the various therapeutic areas of its technology. This chart shows revenue from one of these key medical areas.
Overall market sales
electroCore, Inc. develops non-invasive vagus nerve stimulation devices for the treatment of headaches. The company offers an alternative to traditional medications. Its success depends on the acceptance of this new technology by doctors and patients. This is an example of how medical technology can create new approaches to treating chronic diseases.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company electroCore Inc.
electroCore is a bioelectronic medical company commercializing non-invasive vagus nerve stimulation (nVNS) technology for the treatment of headaches. Its sales forecast depends on the acceptance of this technology by physicians and patients as an alternative to drug treatment.
%20sales%20of%20the%20company%20electroCore%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-electroCore-Inc.&v=1772513430091 "Schedule of future (projected) sales of the company electroCore Inc.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
electroCore, Inc. has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. This chart reflects expectations for the therapeutic medical device sector. It helps assess the demand for non-drug pain treatments and the rate of adoption of new medical devices predicted by analysts.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772513430236 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
electroCore produces non-invasive vagus nerve stimulation devices for the treatment of headaches. Demand for its products depends on physician acceptance and insurance coverage. This chart of overall sales forecasts reflects the state of the economy, which impacts consumer spending on alternative treatments.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513430275 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality electroCore Inc.
electroCore, Inc. is a commercial bioelectronic medical company that has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. This chart shows how sales revenue from this innovative device compares to marketing and research expenses, shaping the company's path to profitability.
Market segment marginality - Therapeutic medical equipment
electroCore is a commercial company offering non-invasive vagus nerve therapy for headaches. Profitability depends on the effectiveness of their commercial team in promoting this innovative treatment. The chart shows how successfully they monetize their technology compared to pharmaceutical companies.
Market marginality as a whole
electroCore, Inc. is a medical company developing non-invasive vagus nerve therapy for headaches. It offers an alternative to medication. This graph shows overall profitability, but for ECOR, success depends on acceptance of its technology by the medical community and patients as an effective, side-effect-free treatment.
Employees in the company, segment and market as a whole
Number of employees in the company electroCore Inc.
electroCore has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. This chart shows the team bringing this new technology to market. Growth, particularly in sales, reflects efforts to educate doctors and patients about the benefits of drug-free therapy.
Share of the company's employees electroCore Inc. within the market segment - Therapeutic medical equipment
electroCore, Inc. has developed a non-invasive device for vagus nerve stimulation to treat headaches. Promoting such an innovative medical device requires a sales and clinical support team. This figure reflects the company's extensive workforce in the bioelectronic medicine sector.
Number of employees in the market segment - Therapeutic medical equipment
electroCore is a medical company that has developed a non-invasive device for vagus nerve stimulation to treat headaches. This chart shows employment in the therapeutic medical equipment sector. The growing number of specialists in this field reflects the search for alternative, drug-free treatments for chronic diseases, which is electroCore's niche.
Number of employees in the market as a whole
electroCore produces non-invasive vagus nerve stimulation devices for the treatment of headaches. Demand for its products is driven by medical needs. This chart shows overall occupancy, but for electroCore, securing insurance company approval for coverage of its therapy is more important.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company electroCore Inc. (ECOR)
electroCore, Inc. produces non-invasive vagus nerve stimulation devices for the treatment of headaches. In the MedTech industry, high market capitalization per employee speaks to the value of patents. This chart shows that investors highly value the technology, which offers a new approach to drug-free treatment.
%20of%20the%20company%20electroCore%20Inc.%20(ECOR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-electroCore-Inc.-ECOR&v=1772513430642 "Chart of market capitalization per employee (in thousands of dollars) of the company electroCore Inc. (ECOR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
electroCore, Inc. is a commercial bioelectronic medical company developing non-invasive vagus nerve therapy. In the MedTech sector, this metric reflects the market valuation of their proprietary technology and commercial potential. How effective is the team at bringing innovative treatments to market?
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772513430657 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
electroCore, Inc. has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. This is an innovative approach to drug-free therapy. The chart shows how the market values the company, whose product, created by a small team, offers a new paradigm in chronic pain treatment.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513430675 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company electroCore Inc. (ECOR)
electroCore (ECOR) is a commercial bioelectronics company that has developed a non-invasive vagus nerve stimulator (gammaCore) for the treatment of headaches. This chart shows how successfully their sales team is selling this innovative, yet niche, medical device to patients and physicians. It measures the effectiveness of the commercialization of this unique technology.
%20Chart%20electroCore%20Inc.%20(ECOR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-electroCore-Inc.-ECOR&v=1772513430697 "Company Profit Per Employee (in thousands of dollars) Chart electroCore Inc. (ECOR)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
electroCore is a bioelectronic medical company that has developed a non-invasive vagus nerve stimulation technology for the treatment of headaches. Success depends on the effective commercialization of this unique product. This graph shows the revenue generated by the sales and marketing team per employee, which benchmarks their performance against other medtech companies.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772513430764 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
electroCore (ECOR) is a company that produces non-invasive devices for vagus nerve stimulation (used to treat headaches). It's a MedTech company. Employee profitability here is a balance between R&D and the sales team's success in promoting this niche device to patients and doctors.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513430801 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee electroCore Inc. (ECOR)
electroCore is a medical device company that has developed a non-invasive vagus nerve stimulation device for the treatment of headaches. This graph shows the commercial trajectory of its product. The growth in revenue per employee reflects the success of sales and the adoption of its technology by both patients and physicians.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-electroCore-Inc.-ECOR&v=1772513430818 "Sales chart per company employee electroCore Inc. (ECOR)")
Sales per employee in the market segment - Therapeutic medical equipment
electroCore is a medical company that developed the gammaCore non-invasive device for vagus nerve stimulation. It is used to treat headaches (migraines and cluster headaches). This graph compares electroCore's revenue per employee to the industry average. This demonstrates how effective their sales team is in promoting this unique device.
Sales per employee for the market as a whole
electroCore (ECOR) is a MedTech company that has developed a non-invasive device (gammaCore) for vagus nerve stimulation to treat headaches (migraines, cluster headaches). It is a commercial company. This chart shows how effectively their sales team promotes this unique device to patients and doctors.
Short shares by company, segment and market as a whole
Shares shorted by company electroCore Inc. (ECOR)
electroCore (ECOR) produces a medical device (gammaCore) for non-invasive vagus nerve stimulation, designed to treat headaches. The company has been fighting for years to get insurance companies to cover the device. This chart shows the number of investors who don't believe this technology will be commercially successful.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-electroCore-Inc.-ECOR&v=1772513430945 "Short Shares Chart for the Company electroCore Inc. (ECOR)")
Shares shorted by market segment - Therapeutic medical equipment
electroCore (ECOR) is a company that developed a non-invasive vagus nerve stimulator (gammaCore) for the treatment of headaches (migraines, cluster headaches). This chart shows the bets against the neuromodulation sector, reflecting investor doubts that patients and doctors will prefer this device to traditional pills.
Shares shorted by the overall market
electroCore (ECOR) is an R&D company developing non-invasive stimulators. This is a speculative bet. When this market fear indicator rises, investors' risk appetite plummets. They sell off unprofitable stocks like ECOR, whose fate depends on R&D.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator electroCore Inc. (ECOR)
electroCore, Inc. produces a non-invasive device (gammaCore) for vagus nerve stimulation used to treat headaches. This indicator tracks how the market views the commercialization of their device, showing "overbought" (above 70) on rising sales or "oversold" (below 30) on weak earnings.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-electroCore-Inc.-ECOR&v=1772513431078 "RSI 14 indicator chart for the company's stock electroCore Inc. (ECOR)")
RSI 14 Market Segment - Therapeutic medical equipment
electroCore is a medical company that developed a non-invasive vagus nerve stimulation technology (gammaCore) for the treatment of headaches (migraines, cluster headaches). This indicator reflects the overall momentum in the therapeutic medical equipment sector and helps determine whether the entire segment is overheated by expectations.
RSI 14 for the overall market
For electroCore, a medical device developer, this chart is a lifeline showing capital availability. During moments of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is turned off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ECOR (electroCore Inc.)
electroCore is a medical technology company that produces a non-invasive vagus nerve stimulator (gammaCore) for the treatment of headaches (migraines, cluster headaches). This chart shows the average analyst forecast. Their targets are based on an increase in prescriptions and an expansion of the device's indications.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ECOR-electroCore-Inc.&v=1772513431144 "A chart showing analyst consensus forecasts for the expected stock price. ECOR (electroCore Inc.)")
The difference between the consensus estimate and the actual stock price ECOR (electroCore Inc.)
electroCore is a medical technology company pioneering non-invasive vagus nerve stimulation (nVNS). Their gammaCore device is used to treat migraines and cluster headaches. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe this non-drug therapy will be commercially successful.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ECOR-electroCore-Inc.&v=1772513431195 "A chart showing the difference between the consensus forecast and the actual stock price. ECOR (electroCore Inc.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
electroCore is a medical device company that produces the "electro-pill" (gammaCore), a non-invasive device that stimulates the vagus nerve to treat migraines and cluster headaches. This chart shows general expectations for the therapeutic medical device sector. It reflects whether experts believe in "neuromodulation."
Analysts' consensus forecast for the overall market share price
electroCore is a medical device company that developed gammaCore, a non-invasive device that utilizes vagus nerve stimulation (VNS) to treat migraines and cluster headaches. This chart shows overall market sentiment. For electroCore, as a company in the commercialization stage, overall optimism is important for funding, but their growth depends more on physician and insurer acceptance of their new technology.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index electroCore Inc.
electroCore is a non-implantable neurostimulator. Their signature device (gammaCore) is a non-invasive (portable) device that stimulates the vagus nerve (nVNS) through the skin of the neck to treat migraines and headaches. This graph summarizes their implementation history, reflecting their (slow) journey to receiving reimbursement from insurance companies and convincing doctors.
AKIMA Market Segment Index - Therapeutic medical equipment
electroCore (ECOR) is a medical device company known for its non-invasive vagus nerve stimulation (nVNS) technology, gammaCore, for the treatment of headaches (migraines and cluster headaches). The chart shows the segment average index, which helps investors assess how successfully ECOR is commercializing its unique technology compared to the industry average.
The AKIM Index for the overall market
electroCore is a bioelectronic medical company that produces non-invasive vagus nerve stimulators (gammaCore) for migraine treatment. This chart, which reflects the market average, provides context. It helps assess how this device's commercialization story compares to overall macroeconomic trends and insurance coverage.
